Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Clinical trial NCT03993353 · COMPLETED

Trial details

NCT number: NCT03993353
Sponsor: University of California, San Diego
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Head and Neck Carcinoma Head and Neck Cancer Stage III Head and Neck Cancer Stage IV Head and Neck Cancer Metastatic Cancer Cancer of Esophagus Cancer, Metastatic Cancer of Head and Neck Cancer of Mouth Cancer of Neck

Start date: 2020-04-07
Primary completion: 2022-04-16
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.